EGFR and lung carcinoma: On the other hand, in China, the same group of 5 oncogenes amounted to 81% of lung cancers, which is largely attributable to the high frequency of EGFR mutations including multiple occurrences of the EGFR mutations as seen in China (Table 4), vs. to non-Asian populations (13, 14).